Thyroid Cancer (Pilot)
Pilot - Not Accredited
Thyroid papillary carcinoma, thyroid follicular carcinoma, poorly differentiated anaplastic thyroid carcinoma, thyroid medullary carcinoma, Phaeochromocytoma, adrenal cortical carcinoma, RET, BRAF, KRAS, NRAS, HRAS, TP53, KRAS, TERT promoter
PURPOSE OF PROGRAMME:
Testing for somatic small nucelotide variants in thryoid cancer.
MATERIAL PROVIDED: DNA in TE buffer
DISTRIBUTIONS PER YEAR: 1
SAMPLES PER DISTRIBUTION: 3
FREQUENCY OF DISTRIBUTION: 1
PROGRAMME OF ANALYSIS:
Small variant analysis only
Details of the performance criteria for this programme can be obtained from UK NEQAS Genomics (GenQA) directly.
Telephone: +44 (0) 131 2426898
GenQA (Genomics Quality Assessment) provides external quality assessment (EQA) / proficiency testing (PT) to the genomics community worldwide. GenQA EQAs cover the entire clinical genomics service from patient counselling, sample preparation, testing processes, results interpretation and reporting. Laboratories and individual clinicians have access to more than 100 unique EQAs available for a range of rare and inherited disorders and acquired diseases. Please click here for an overview of GenQA